Anzeige
Mehr »
Login
Donnerstag, 14.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Investment in die Zukunft: Absoluter Geheimtipp - diese Aktie beschleunigt deine Renditechancen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 906006 | ISIN: US1271903049 | Ticker-Symbol: CA8A
Tradegate
13.11.24
21:53 Uhr
513,00 Euro
-0,50
-0,10 %
Branche
Internet
Aktienmarkt
S&P MidCap 400
1-Jahres-Chart
CACI INTERNATIONAL INC Chart 1 Jahr
5-Tage-Chart
CACI INTERNATIONAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
514,50519,5011:23
515,50519,5011:24
ACCESSWIRE
530 Leser
Artikel bewerten:
(2)

CACI: Employee Profile: Spotlighting Command Sgt. Maj. William F. Thetford, U.S. Army

Finanznachrichten News

NORTHAMPTON, MA / ACCESSWIRE / December 21, 2023 / CACI

Command Sgt. Maj. William F. Thetford, U.S. Army (Ret.) passionately strives to be the driving force behind mission success in all that he does.

As a high-school student in 1980, Thetford recalls feeling helpless while watching the news after Iranian militants overran the U.S. Embassy in Tehran, and the subsequent hostage rescue mission failed.

"I knew then that if our country ever had to conduct another mission of that significance, I wanted to be a part of that effort," he said. "This began my journey into serving the nation and the Special Operations community." Thetford completed his initial training for Infantry and Airborne at Ft. Benning the following year.

Before joining CACI, Thetford dedicated over 35 years to Special Operations, serving in roles within the Ranger Regiment and Special Missions Unit. He was later chosen to assume the position of Senior Enlisted Leader at the Joint Special Operations Command (JSOC) and the Special Operations Command (SOCOM) and concluded his military career in 2019 as the Command Senior Enlisted Leader of U.S. Central Command.

In October 1993, Thetford played a pivotal role in the intense conflict known as the Battle of Mogadishu. While assigned to Task Force Ranger, he actively participated in the notorious two-day battle against Somalian forces and completed the now-famous Mogadishu Mile. In recognition of his heroic actions, Thetford was awarded the Distinguished Service Cross, the nation's second-highest award for valor.

During his exceptional military career, Thetford recognized the crucial nature of leading a team by example. "It's hard for me to imagine a worthy leader who will not perform at a level of what they expect of their people or work as hard as their subordinates in their duties," he said.

Accompanied by his unwavering commitment and support, Thetford joined CACI in 2019 and now serves as a Project Manager for the Special Operations Forces Emerging Threats, Operations, and Planning Support (SOFETOPS) contract. His strategic vision and drive set the standard for his team as they deliver expertise in integrated information warfare (IW) and electronic warfare (EW) solutions, training, readiness, and modernization to advance Army Special Operations Command (USASOC) missions.

Thetford has found that at CACI, upholding its culture of boundless ingenuity and opportunity takes precedence above all else. He nods to CACI President and CEO John Mengucci for fostering an environment in which employees can harness their talents and add value to the company's mission daily.

"This empowered culture that emphasizes a 'bias for action' was present in my experience in the Joint Special Operations Command and is the propulsion behind CACI's success today," he said. "I am so grateful to be a part of a company whose culture and mission are so deeply intertwined with that of the armed forces."

CACI serves as an organization in which employees are given the autonomy, trust, and support they need to thrive. Explore veteran career opportunities at CACI.

ABOUT CACI

At CACI International Inc (NYSE: CACI), our 23,000 talented and dynamic employees are ever vigilant in delivering distinctive expertise and differentiated technology to meet our customers' greatest challenges in national security and government modernization. We are a company of good character, relentless innovation, and long-standing excellence. Our culture drives our success and earns us recognition as a Fortune World's Most Admired Company. CACI is a member of the Fortune 1000 Largest Companies, the Russell 1000 Index, and the S&P MidCap 400 Index. For more information, visit us at caci.com.

Corporate Communications and Media:

Lorraine Corcoran

Executive Vice President, Corporate Communications

(703) 434-4165, lorraine.corcoran@caci.com

Sgt. Maj. William F. Thetford, U.S. Army (Ret.) pictured during his active-duty service and in his continued mission as a CACI employee.

View additional multimedia and more ESG storytelling from CACI on 3blmedia.com.

Contact Info:
Spokesperson: CACI
Website: https://www.3blmedia.com/profiles/caci
Email: info@3blmedia.com

SOURCE: CACI



View the original press release on accesswire.com

© 2023 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.